Skip to main content

Phase I, II, III, and IV Studies: Good Clinical Practice

  • Chapter
Trends in Contrast Media

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 248 Accesses

Abstract

The development of new medicines, including drugs, for use in radiology has made it possible to diagnose, treat, and prevent a number of previously refractory diseases. Due to the necessary intensification of demands by the health authorities, the time required to develop new drugs has increased. Regulations have come into force regarding both production processes (Good Manufacturing Practice, GMP) and preclinical investigational programs (Good Laboratory Practice, GLP).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ankier SI, Warrington SJ (1989) Research and development of new medicines. J Int Med Res 17:407–416.

    PubMed  CAS  Google Scholar 

  • Commission of the European Communities (1990) Good Clinical Practice for Trials on Medicinal Products in the European Community. In: The rules governing medicinal products in the European Community, vol. Ill, addendum July 1990, pp 57–98.

    Google Scholar 

  • Hvidberg EF (1994) Clinical trials on medicinal products (in Danish). Ugeskr Laeger 156:789–793.

    PubMed  CAS  Google Scholar 

  • Legrand C, Cheix F, Dumais H, Laugel V, De Cremier F, Dupont C (1995) Clinical trial initiation procedures in Europe: the legal framework and practical aspects. Drug Information J 29:201–259.

    Google Scholar 

  • The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit (1996) Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95).

    Google Scholar 

  • World Health Organization (1993) WHO Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products. Division of drug management and policies.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stilbo, I.M. (1999). Phase I, II, III, and IV Studies: Good Clinical Practice. In: Thomsen, H.S., Muller, R.N., Mattrey, R.F. (eds) Trends in Contrast Media. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59814-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59814-2_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64136-7

  • Online ISBN: 978-3-642-59814-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics